These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27681076)

  • 21. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
    Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
    Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and Clinical Significance of TTF-1 and p63 in NSCLC.].
    Zhang P; Han Y; Huang L; Li Q; Ma D
    Zhongguo Fei Ai Za Zhi; 2009 Sep; 12(9):995-9. PubMed ID: 20719198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
    Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus.
    Boelens MC; van den Berg A; Vogelzang I; Wesseling J; Postma DS; Timens W; Groen HJ
    J Clin Pathol; 2007 Jun; 60(6):608-14. PubMed ID: 16489176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Desmoglein 3 (DSG3) as a Sensitive and Specific Marker for Esophageal Squamous Cell Carcinoma.
    Chi Z; Balani J; Gopal P; Hammer S; Lewis CM; Peng L
    Gastroenterol Res Pract; 2022; 2022():2220940. PubMed ID: 35251162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome.
    Righi L; Vavalà T; Rapa I; Vatrano S; Giorcelli J; Rossi G; Capelletto E; Novello S; Scagliotti GV; Papotti M
    J Thorac Oncol; 2014 Oct; 9(10):1540-6. PubMed ID: 25521399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of AGR2 and KRT5 as an immunomarker combination in distinguishing lung squamous cell carcinoma from adenocarcinoma.
    Pan B; Wei ZX; Zhang JX; Li X; Meng QW; Cao YY; Qi LS; Yu Y
    Am J Transl Res; 2021; 13(5):4464-4476. PubMed ID: 34150027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
    Nobre AR; Albergaria A; Schmitt F
    Acta Cytol; 2013; 57(1):1-8. PubMed ID: 23221041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
    Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
    Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of p63 and CK5/6 in early-stage lung squamous cell carcinoma is not only an early diagnostic indicator but also correlates with a good prognosis.
    Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Xiong H; Liang Z; Yan W; Chen K
    Thorac Cancer; 2015 May; 6(3):288-95. PubMed ID: 26273374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
    Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M
    J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas.
    Kargi A; Gurel D; Tuna B
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):415-20. PubMed ID: 18091384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of serum squamous cell carcinoma antigen in surgically treated lung cancer.
    Takeuchi S; Nonaka M; Kadokura M; Takaba T
    Ann Thorac Cardiovasc Surg; 2003 Apr; 9(2):98-104. PubMed ID: 12732086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
    Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
    Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
    Zhang C; Schmidt LA; Hatanaka K; Thomas D; Lagstein A; Myers JL
    Am J Clin Pathol; 2014 Sep; 142(3):320-4. PubMed ID: 25125621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.
    Shinmura K; Igarashi H; Kato H; Kawanishi Y; Inoue Y; Nakamura S; Ogawa H; Yamashita T; Kawase A; Funai K; Sugimura H
    Dis Markers; 2014; 2014():619273. PubMed ID: 25548429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High coexpression of both EGFR and IGF1R correlates with poor patient prognosis in resected non-small-cell lung cancer.
    Gately K; Forde L; Cuffe S; Cummins R; Kay EW; Feuerhake F; O'Byrne KJ
    Clin Lung Cancer; 2014 Jan; 15(1):58-66. PubMed ID: 24210543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
    Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
    Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer.
    Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E
    Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.